Differential gene expression of steroid 5α-reductase 2 in core needle biopsies from malignant and benign prostatic tissue

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 7, 1997, Pages 2210-2214

  Bjelfman, Catarina ^a   Söderström, Torbjörn G ^a   Brekkan, Einar ^a   Norlén, Bo Johan ^a   Egevad, Lars ^a   Unge, Torsten ^b   Andersson, Stefan ^c   Rane, Anders ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; MESSENGER RNA; PROSTATE SPECIFIC ANTIGEN; STEROID 5ALPHA REDUCTASE; TESTOSTERONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NEEDLE BIOPSY; PRIORITY JOURNAL; PROSTATE CANCER;

AGE FACTORS; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; GENE EXPRESSION; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RNA, MESSENGER; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 0030856520     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.7.2210     Document Type: Article

References (18)

1. Garraway WM, Russell EB, Lee RJ, et al. 1993 Impact of previously unrecognized benign prostatic hyperplasia on the daily activities of middle-aged and elderly men. Br J Gen Pract. 43:318-321.
2. National Board of Health and Welfare in Sweden. 1995 Cancer i siffror (Swedish). Centre of Epidemiology, Stockholm, Sweden.
3. Huggins C, Stevens R, Hodges CV. 1941 Studies on prostate cancer. II. The effect of castration on advanced carcinoma of the prostate gland. Arch Surg. 43:209-233.
4. Wilson JD, Griffin JE, Russell DW. 1993 Steroid 5α-reductase 2 deficiency. Endocr Rev. 14:577-593.
5. Martel C, Rhéaume E, Takahashi M, et al. 1992 Distribution of 170-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues. J Steroid Biochem Mol Biol. 41:597-603.
6. Martini L. 1982 The 5 alpha-reduction of testosterone in the neuroendocrine structures. Biochemical and physiological implications. Endocr Rev. 3:1-25.
7. Andersson S, Russel DW. 1990 Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci USA. 87:3640-3644.
8. Andersson S, Berman DM, Jenkins EP, Russell DW. 1991 Deletion of steroid 5α-reductase 2 gene in male pseudohermaphroditism. Nature. 354:159-161.
9. Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW. 1992 Genetic and pharmacological evidence for more than one human steroid 5α-reductase J Clin Invest. 89:293-300.
10. Weisser H, Tunn S, Debus M, Krieg M. 1994 5α-reductase inhibition by finasterid (Proscar®) in epithelium and stroma of human benign prostatic hyperplasia. Steroids. 59:616-620.
11. Stoner E. 1990 The clinical development of a 5α-reductase inhibitor, finasterid. J Steroid Biochem Mol Biol. 37:375-378.
12. Gormley GJ, Stoner E, Bruskewitz RC, et al. 1992 The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med. 327:1185-1191.
13. Silver RF, Wiley EK, Thigpen AE, Guileyardo JM, McConnell JD, Russell DW. 1994 Cell type specific expression of steroid 5α-reductase 2. J Urol. 152:438-442.
14. Cunha GR. 1976 Epithelial-stromal interaction in development of the urogenital tract. Int Rev Cytol. 47:137-194.
15. Durnam DM, Palmiter RD. 1983 A practical approach for quantitating specific mRNA by solution hybridization. Anal Biochem. 131:385-393.
16. Melton DM, Krieg PA, Rebagliati MR, et al. 1984 Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing bacteriophage SP6 promoter. Nucleic Acid Res. 12:7035-7056.
17. Elo JP, Akinola LA, Poutanen M, Vihko P, Kyllonen AP, Lukkarinen O, Vihko R. 1996 Characterization of 17 beta-hydroxysteroid dehydrogenase isoenzyme expression in benign and malignant human prostate. Int J Cancer. 66:37-41.
18. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. 1993 Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest. 92:903-910.